Rheumatoid arthritis: advances in treatment strategies

P Prasad, S Verma, Surbhi, NK Ganguly… - Molecular and cellular …, 2023 - Springer
Rheumatoid arthritis (RA) is characterised by severe joint and bone damage due to
heightened autoimmune response at the articular sites. Worldwide annual incidence and …

[HTML][HTML] Management of rheumatoid arthritis: an overview

AF Radu, SG Bungau - Cells, 2021 - mdpi.com
Rheumatoid arthritis (RA) is a multifactorial autoimmune disease of unknown etiology,
primarily affecting the joints, then extra-articular manifestations can occur. Due to its …

[HTML][HTML] Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis

YJ Lin, M Anzaghe, S Schülke - Cells, 2020 - mdpi.com
Rheumatoid arthritis (RA) is an autoimmune disease that involves multiple joints bilaterally.
It is characterized by an inflammation of the tendon (tenosynovitis) resulting in both cartilage …

Biological therapies for rheumatoid arthritis: an overview for the clinician

KE Findeisen, J Sewell, AJK Ostor - Biologics: Targets and Therapy, 2021 - Taylor & Francis
Rheumatoid arthritis (RA) is a disease characterised by inflammation of synovial joints and
poses a substantial healthcare burden on both the individual and society. One of the most …

Treatment of rheumatoid arthritis: unraveling the conundrum

E Zampeli, PG Vlachoyiannopoulos, AG Tzioufas - Journal of autoimmunity, 2015 - Elsevier
Rheumatoid arthritis (RA) is a heterogeneous disease with a complex and yet not fully
understood pathophysiology, where numerous different cell-types contribute to a destructive …

[HTML][HTML] Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis

RB Mrid, N Bouchmaa, H Ainani, R El Fatimy… - Biomedicine & …, 2022 - Elsevier
Rheumatoid arthritis (RA) is one of more than 100 types of arthritis. This chronic autoimmune
disorder affects the lining of synovial joints in about 0.5% of people and may induce severe …

[HTML][HTML] Promising therapeutic targets for treatment of rheumatoid arthritis

J Huang, X Fu, X Chen, Z Li, Y Huang… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that
mainly damages the hands and feet, which affects 0.5% to 1.0% of the population …

[HTML][HTML] Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?

VC Romão, EM Vital, JE Fonseca, MH Buch - Arthritis research & therapy, 2017 - Springer
Individualising biologic disease-modifying anti-rheumatic drugs (bDMARDs) to maximise
outcomes and deliver safe and cost-effective care is a key goal in the management of …

Rheumatoid arthritis: an overview of new and emerging therapies

T Doan, E Massarotti - The Journal of Clinical Pharmacology, 2005 - Wiley Online Library
Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic autoimmune disorder
characterized by symmetric inflammation of synovial joints leading to progressive erosion of …

[HTML][HTML] Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies

AL Mueller, Z Payandeh, N Mohammadkhani… - Cells, 2021 - mdpi.com
Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and
progressive autoimmune disease affecting many people worldwide. While patients show …